$226 Million is the total value of ARMISTICE CAPITAL, LLC's 27 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 96.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Buy | SPDR S&P 500 ETF TRput | $30,965,000 | +201.3% | 150,000 | +200.0% | 13.72% | +177.9% |
VNDA | Buy | VANDA PHARMACEUTICALS INC | $21,241,000 | +103.8% | 2,284,000 | +213.7% | 9.41% | +87.9% |
RXDX | Buy | IGNYTA INC | $17,711,000 | +70.9% | 1,780,000 | +17.6% | 7.85% | +57.6% |
SPPI | Buy | SPECTRUM PHARMACEUTICALS INC | $16,389,000 | +15.3% | 2,700,000 | +31.6% | 7.26% | +6.3% |
KODK | Buy | EASTMAN KODAK CO | $11,394,000 | +11.7% | 600,000 | +27.7% | 5.05% | +3.0% |
BCOR | New | BLUCORA INC | $10,573,000 | – | 774,000 | +100.0% | 4.69% | – |
PBY | Buy | PEP BOYS MANNY MOE & JACK | $10,486,000 | +15.1% | 1,090,000 | +17.5% | 4.65% | +6.1% |
ATRS | Buy | ANTARES PHARMA INC | $10,298,000 | +54.1% | 3,800,000 | +46.2% | 4.56% | +42.1% |
VCRA | Buy | VOCERA COMMUNICATIONS INC | $8,988,000 | +1.5% | 906,000 | +6.6% | 3.98% | -6.4% |
TBPH | New | THERAVANCE BIOPHARMA INC | $8,883,000 | – | 512,000 | +100.0% | 3.94% | – |
WIFI | Buy | BOINGO WIRELESS INC | $8,671,000 | +5.7% | 1,150,000 | +7.5% | 3.84% | -2.6% |
APOL | New | APOLLO ED GROUP INCcl a | $7,568,000 | – | 400,000 | +100.0% | 3.35% | – |
KZ | Buy | KONGZHONG CORPsponsored adr | $6,913,000 | +6.7% | 1,250,000 | +4.4% | 3.06% | -1.5% |
QLGC | Sell | QLOGIC CORP | $6,898,000 | -19.3% | 468,000 | -27.1% | 3.06% | -25.6% |
PGNX | New | PROGENICS PHARMACEUTICALS IN | $6,865,000 | – | 1,148,000 | +100.0% | 3.04% | – |
SNAK | New | INVENTURE FOODS INC | $6,714,000 | – | 600,000 | +100.0% | 2.98% | – |
SNTA | New | SYNTA PHARMACEUTICALS CORP | $6,286,000 | – | 3,240,000 | +100.0% | 2.79% | – |
IAC | Sell | IAC INTERACTIVECORP | $6,072,000 | -22.0% | 90,000 | -29.7% | 2.69% | -28.0% |
LL | New | LUMBER LIQUIDATORS HLDGS INC | $5,540,000 | – | 180,000 | +100.0% | 2.46% | – |
DMD | New | DEMAND MEDIA INC | $5,240,000 | – | 916,000 | +100.0% | 2.32% | – |
FHCO | Buy | FEMALE HEALTH CO | $3,187,000 | +20.6% | 1,126,000 | +67.1% | 1.41% | +11.2% |
NSPR | New | INSPIREMD INC | $2,240,000 | – | 7,000,000 | +100.0% | 0.99% | – |
OSTK | New | OVERSTOCK COM INC DEL | $1,720,000 | – | 71,000 | +100.0% | 0.76% | – |
RPTP | Sell | RAPTOR PHARMACEUTICAL CORP | $1,413,000 | -83.2% | 130,000 | -83.8% | 0.63% | -84.5% |
IMUC | New | IMMUNOCELLULAR THERAPEUTICS | $1,199,000 | – | 2,471,500 | +100.0% | 0.53% | – |
IRGTQ | New | IGNITE RESTAURANT GROUP INC | $1,164,000 | – | 240,000 | +100.0% | 0.52% | – |
NERV | New | MINERVA NEUROSCIENCES INC | $1,013,000 | – | 202,634 | +100.0% | 0.45% | – |
RTRX | Exit | RETROPHIN INC | $0 | – | -34,874 | -100.0% | -0.20% | – |
UNXLQ | Exit | UNI PIXEL INC | $0 | – | -176,000 | -100.0% | -0.48% | – |
DRRX | Exit | DURECT CORP | $0 | – | -3,849,266 | -100.0% | -1.46% | – |
Exit | CENVEO CORPnote 7.000% 5/1 | $0 | – | -3,752 | -100.0% | -1.79% | – | |
Exit | EXELIXIS INCnote 4.250% 8/1 | $0 | – | -6,678 | -100.0% | -1.82% | – | |
BSTC | Exit | BIOSPECIFICS TECHNOLOGIES CO | $0 | – | -105,000 | -100.0% | -1.95% | – |
KND | Exit | KINDRED HEALTHCARE INC | $0 | – | -234,000 | -100.0% | -2.04% | – |
UNTD | Exit | UNITED ONLINE INC | $0 | – | -350,000 | -100.0% | -2.45% | – |
URBN | Exit | URBAN OUTFITTERS INC | $0 | – | -172,000 | -100.0% | -2.90% | – |
LF | Exit | LEAPFROG ENTERPRISES INCcl a | $0 | – | -1,500,000 | -100.0% | -3.40% | – |
TIME | Exit | TIME INC NEW | $0 | – | -310,000 | -100.0% | -3.67% | – |
AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -372,000 | -100.0% | -3.74% | – |
SODA | Exit | SODASTREAM INTERNATIONAL LTD | $0 | – | -430,000 | -100.0% | -4.16% | – |
HPTX | Exit | HYPERION THERAPEUTICS INC | $0 | – | -434,000 | -100.0% | -5.00% | – |
ZGNX | Exit | ZOGENIX INC | $0 | – | -9,400,000 | -100.0% | -6.19% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
INCYTE CORP | 21 | Q3 2023 | 2.8% |
VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.